The firm's listing covers sectors AI, Healthcare and SaaS, and focus areas AI Infrastructure, Data Analytics, Digital Health and Drug Discovery; listed stages are Series A and Series B.

Vab Goel (Investor) and Andrew Fleming (Investor) are listed as the contacts to pitch at Nference.

Nference shares portfolio companies with 3 other investment firms, among them Boston Scientific, NTTVC and Matrix Capital Management.

Frequently asked questions

What is Nference?

Nference is a corporate venture arm based in Cambridge, Massachusetts, United States, with a known portfolio of one company. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Nference invest in?

Listed sectors include AI, Healthcare and SaaS; listed focus areas include AI Infrastructure, Data Analytics, Digital Health and Drug Discovery. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Nference invest at?

Nference is listed for Series A and Series B rounds in the database. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Nference?

Both people on file at Nference are listed as contacts for the firm, each with their own profile page.

How do I contact Nference?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 2 people attached to the firm have their own pages, each showing whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal